Search Results - "Schmidt, Peter M"

Refine Results
  1. 1

    The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells by Eljaschewitsch, Eva, Witting, Anke, Mawrin, Christian, Lee, Thomas, Schmidt, Peter M., Wolf, Susanne, Hoertnagl, Heide, Raine, Cedric S., Schneider-Stock, Regine, Nitsch, Robert, Ullrich, Oliver

    Published in Neuron (Cambridge, Mass.) (05-01-2006)
    “…Endocannabinoids are released after brain injury and believed to attenuate neuronal damage by binding to CB 1 receptors and protecting against excitotoxicity…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses by Barrett, Susan, Mohr, Peter G, Schmidt, Peter M, McKimm-Breschkin, Jennifer L

    Published in PloS one (17-08-2011)
    “…The influenza neuraminidase (NA) inhibitors zanamivir, oseltamivir and peramivir were all designed based on the knowledge that the transition state analogue of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A generic system for the expression and purification of soluble and stable influenza neuraminidase by Schmidt, Peter M, Attwood, Rebecca M, Mohr, Peter G, Barrett, Susan A, McKimm-Breschkin, Jennifer L

    Published in PloS one (07-02-2011)
    “…The influenza surface glycoprotein neuraminidase (NA) is essential for the efficient spread of the virus. Antiviral drugs such as Tamiflu (oseltamivir) and…”
    Get full text
    Journal Article
  7. 7

    Taking down the FLAG! How insect cell expression challenges an established tag-system by Schmidt, Peter M, Sparrow, Lindsay G, Attwood, Rebecca M, Xiao, Xiaowen, Adams, Tim E, McKimm-Breschkin, Jennifer L

    Published in PloS one (06-06-2012)
    “…In 1988 the preceding journal of Nature Biotechnology, Bio/Technology, reported a work by Hopp and co-workers about a new tag system for the identification and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Identification of Residues Crucially Involved in the Binding of the Heme Moiety of Soluble Guanylate Cyclase by Schmidt, Peter M., Schramm, Matthias, Schröder, Henning, Wunder, Frank, Stasch, Johannes-Peter

    Published in The Journal of biological chemistry (23-01-2004)
    “…Soluble guanylate cyclase (sGC), a heterodimeric hemeprotein, is the only receptor for the biological messenger nitric oxide (NO) identified to date and is…”
    Get full text
    Journal Article
  10. 10

    Technical Optimization for the High-Throughput Purification of Antibodies on Automated Liquid Handlers by Schmidt, Peter M

    “…Monoclonal antibodies (mAbs) are the fastest-growing segment in the drug market with eight of the top 20 selling drugs being mAbs and combined sales of close…”
    Get more information
    Journal Article
  11. 11

    Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells by Hoffmann, Linda S, Schmidt, Peter M, Keim, Yvonne, Hoffmann, Carsten, Schmidt, Harald H H W, Stasch, Johannes-Peter

    Published in PloS one (17-08-2011)
    “…In cardiovascular disease, the protective NO/sGC/cGMP signalling-pathway is impaired due to a decreased pool of NO-sensitive haem-containing sGC accompanied by…”
    Get full text
    Journal Article
  12. 12

    Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo by Rothkegel, Christiane, Schmidt, Peter M, Atkins, Derek-John, Hoffmann, Linda Sarah, Schmidt, Harald H H W, Schröder, Henning, Stasch, Johannes-Peter

    Published in Molecular pharmacology (01-11-2007)
    “…The ubiquitously expressed nitric oxide (NO) receptor soluble guanylate cyclase (sGC) plays a key role in signal transduction. Binding of NO to the N-terminal…”
    Get more information
    Journal Article
  13. 13

    Identification of a modified coagulation factor X with enhanced activation properties as potential hemostatic agent by Ebert, Mariana, Raquet, Elmar, Schweisgut, Sabine, Schmidt, Peter M., Weimer, Thomas

    Published in Blood cells, molecules, & diseases (01-07-2021)
    “…Hemophilia A and hemophilia B are X-linked inherited bleeding disorders caused by a deficiency of coagulation factor VIII and IX, respectively. Standard of…”
    Get full text
    Journal Article
  14. 14

    Identification of residues crucially involved in soluble guanylate cyclase activation by Rothkegel, Christiane, Schmidt, Peter M., Stoll, Friederike, Schröder, Henning, Schmidt, Harald H.H.W., Stasch, Johannes-Peter

    Published in FEBS letters (24-07-2006)
    “…The ubiquitous heterodimeric nitric oxide (NO) receptor soluble guanylate cyclase (sGC) plays a key role in various signal transduction pathways. Binding of NO…”
    Get full text
    Journal Article
  15. 15

    NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential by Evgenov, Oleg V, Pacher, Pál, Schmidt, Peter M, Haskó, György, Schmidt, Harald H. H. W, Stasch, Johannes-Peter

    Published in Nature reviews. Drug discovery (01-09-2006)
    “…Soluble guanylate cyclase (sGC) is a key signal-transduction enzyme activated by nitric oxide (NO). Impaired bioavailability and/or responsiveness to…”
    Get full text
    Journal Article
  16. 16

    Detection of activity of telomerase in tumor cells using fiber optical biosensors by Schmidt, Peter M, Lehmann, Christine, Matthes, Eckart, Bier, Frank F

    Published in Biosensors & bioelectronics (01-12-2002)
    “…Human telomerase plays an important role in the cancerogenesis as it is up-regulated in 80–90% of malignant tumors. Thus, it is considered as a potential…”
    Get full text
    Journal Article
  17. 17

    NO- and haem-independent soluble guanylate cyclase activators by Schmidt, Harald H H W, Schmidt, Peter M, Stasch, Johannes-Peter

    “…Oxidative stress, a risk factor for several cardiovascular disorders, interferes with the NO/sGC/cGMP signalling pathway through scavenging of NO and formation…”
    Get more information
    Journal Article
  18. 18

    A robust robotic high-throughput antibody purification platform by Schmidt, Peter M., Abdo, Michael, Butcher, Rebecca E., Yap, Min-Yin, Scotney, Pierre D., Ramunno, Melanie L., Martin-Roussety, Genevieve, Owczarek, Catherine, Hardy, Matthew P., Chen, Chao-Guang, Fabri, Louis J.

    Published in Journal of Chromatography A (15-07-2016)
    “…•Two stage robust antibody purification platform has been established.•High yield preparative antibody purification for initial screening…”
    Get full text
    Journal Article
  19. 19

    Optimizing high throughput antibody purification by using continuous chromatography media by Butcher, Rebecca E., Martin-Roussety, Genevieve, Bradford, Rebecca A., Tester, Andrea, Owczarek, Catherine, Hardy, Matthew P., Chen, Chao-Guang, Sansome, Georgina, Fabri, Louis J., Schmidt, Peter M.

    Published in Protein expression and purification (01-07-2019)
    “…The ability to engineer monoclonal antibodies (mAbs) with high specificity made mAbs the fastest growing segment in the drug market. mAbs represent 8 of the…”
    Get full text
    Journal Article
  20. 20

    Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion‐domain stalk by Streltsov, Victor A., Schmidt, Peter M., McKimm-Breschkin, Jennifer L.

    “…The influenza neuraminidase (NA) is a homotetramer with head, stalk, transmembrane and cytoplasmic regions. The structure of the NA head with a stalk has never…”
    Get full text
    Journal Article